Early Circulating Tumour DNA Variations Predict Tumour Response in Melanoma Patients Treated with Immunotherapy

• मुख्य लेखकों: Laura Keller (लेखक), Nicolas Guibert (लेखक), Anne Casanova (लेखक), Stephanie Brayer (लेखक), Magali Farella (लेखक), Myriam Delaunay (लेखक), Julia Gilhodes (लेखक), Elodie Martin (लेखक), Gisèle Balagué (लेखक), Gilles Favre (लेखक), Anne Pradines (लेखक), Nicolas Meyer (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Medical Journals Sweden, 2018-11-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Antibodies targeting immune checkpoints were recently approved for metastatic melanoma. However, not all patients will respond to the treatment and some will experience grade III-IV immune-related adverse events. Therefore, early identification of non-responder patients would greatly aid clinical pr...